Found: 43
Select item for more details and to access through your institution.
Elimination of HDV: Epidemiologic implications and public health perspectives.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 101, doi. 10.1111/liv.15579
- By:
- Publication type:
- Article
Bulevirtide for patients with compensated chronic hepatitis delta: A review.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 80, doi. 10.1111/liv.15389
- By:
- Publication type:
- Article
Treatment of hepatitis delta and HIV infection.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 108, doi. 10.1111/liv.15345
- By:
- Publication type:
- Article
Hepatocellular carcinoma: The virus or the liver?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 22, doi. 10.1111/liv.15253
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. i, doi. 10.1111/liv.15713
- Publication type:
- Article
Hepatitis Delta: Ready for primetime?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 1, doi. 10.1111/liv.15679
- By:
- Publication type:
- Article
Natural history of untreated HDV patients: Always a progressive disease?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 5, doi. 10.1111/liv.15467
- By:
- Publication type:
- Article
Diagnosis of HDV: From virology to non‐invasive markers of fibrosis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 31, doi. 10.1111/liv.15515
- By:
- Publication type:
- Article
Treatment endpoints for chronic hepatitis D.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 60, doi. 10.1111/liv.15447
- By:
- Publication type:
- Article
Immunology of hepatitis D virus infection: General concepts and present evidence.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 47, doi. 10.1111/liv.15424
- By:
- Publication type:
- Article
Emerging anti‐HDV drugs and HBV cure strategies with anti‐HDV activity.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 87, doi. 10.1111/liv.15417
- By:
- Publication type:
- Article
Interferon‐based treatment of chronic hepatitis D.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 69, doi. 10.1111/liv.15410
- By:
- Publication type:
- Article
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 96, doi. 10.1111/liv.15352
- By:
- Publication type:
- Article
Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 116, doi. 10.1111/liv.15338
- By:
- Publication type:
- Article
Look for new biomarkers in the management of hepatocellular carcinoma: What the hepatologists may need to know.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 260, doi. 10.1111/liv.15483
- By:
- Publication type:
- Article
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 258, doi. 10.1111/liv.15482
- By:
- Publication type:
- Article
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 6, doi. 10.1111/liv.15474
- By:
- Publication type:
- Article
Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 221, doi. 10.1111/liv.15466
- By:
- Publication type:
- Article
A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 77, doi. 10.1111/liv.15465
- By:
- Publication type:
- Article
Hepatic Leukaemia.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 8, doi. 10.1111/liv.15419
- By:
- Publication type:
- Article
Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 155, doi. 10.1111/liv.15435
- By:
- Publication type:
- Article
Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 160, doi. 10.1111/liv.15293
- By:
- Publication type:
- Article
Response to "Hepatitis delta virus infection in the Middle East".
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 257, doi. 10.1111/liv.15451
- By:
- Publication type:
- Article
Hepatitis delta virus infection in the Middle East.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 256, doi. 10.1111/liv.15450
- By:
- Publication type:
- Article
Apolipoprotein A‐1 protected hepatic ischaemia–reperfusion injury through suppressing macrophage pyroptosis via TLR4–NF‐κB pathway.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 234, doi. 10.1111/liv.15448
- By:
- Publication type:
- Article
Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 90, doi. 10.1111/liv.15415
- By:
- Publication type:
- Article
Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 60, doi. 10.1111/liv.15414
- By:
- Publication type:
- Article
Immunogenicity of COVID‐19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta‐analysis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 34, doi. 10.1111/liv.15403
- By:
- Publication type:
- Article
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 208, doi. 10.1111/liv.15383
- By:
- Publication type:
- Article
A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 115, doi. 10.1111/liv.15378
- By:
- Publication type:
- Article
HCV point of care screening in people tested for SARS‐CoV‐2 in a social‐housing neighbourhood of Milan, Italy.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 251, doi. 10.1111/liv.15375
- By:
- Publication type:
- Article
Altered ethanol metabolism and increased oxidative stress enhance alcohol‐associated liver injury in farnesoid X receptor‐deficient mice.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 100, doi. 10.1111/liv.15374
- By:
- Publication type:
- Article
Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 69, doi. 10.1111/liv.15372
- By:
- Publication type:
- Article
TRIM27‐USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 194, doi. 10.1111/liv.15346
- By:
- Publication type:
- Article
Pulmonary impairment independently determines mortality in critically ill patients with acute‐on‐chronic liver failure.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 180, doi. 10.1111/liv.15343
- By:
- Publication type:
- Article
Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 147, doi. 10.1111/liv.15340
- By:
- Publication type:
- Article
Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 18, doi. 10.1111/liv.15313
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 1, doi. 10.1111/liv.15298
- Publication type:
- Article
FIB‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 170, doi. 10.1111/liv.15295
- By:
- Publication type:
- Article
Portal pressure is of significant prognostic value in primary biliary cholangitis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 139, doi. 10.1111/liv.15289
- By:
- Publication type:
- Article
Impact on follow‐up strategies in patients with primary sclerosing cholangitis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 127, doi. 10.1111/liv.15286
- By:
- Publication type:
- Article
Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 49, doi. 10.1111/liv.15285
- By:
- Publication type:
- Article